close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

LLY

1,000.74

-0.73%↓

JNJ

243.67

+0.49%↑

ABBV

226.66

-0.51%↓

NVS

161.54

-0.79%↓

AZN

195.13

+0.21%↑

Home・Aandelen Lijst・Cellectar Biosciences Inc
Search

Cellectar Biosciences Inc

Gesloten

3.01 10.66

Buy

Prijsupdate 10 mrt 2026, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.7

Max

3.27

Belangrijke statistieken

By Trading Economics

Werknemers

11

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+407.25% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

15M

Vorige openingsprijs

-7.65

Vorige sluitingsprijs

3.01

Cellectar Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 mrt 2026, 20:38 UTC

Winsten

Oracle Raises 2027 Sales Outlook Amid AI Demand, Restructuring

DJ

Lezen

10 mrt 2026, 23:57 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

10 mrt 2026, 23:57 UTC

Marktinformatie

Risks Rising on Australian Bank Valuation Multiples -- Market Talk

DJ

Lezen

10 mrt 2026, 23:47 UTC

Marktinformatie

Nikkei May Rise as Concerns About Energy Costs Ease -- Market Talk

DJ

Lezen

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Acquire Poseidon Stake for US$825.7M

DJ

Lezen

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Buy 10% Stake in Poseidon

DJ

Lezen

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Fund Deal With Internal Cash Resources

DJ

Lezen

10 mrt 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Yangzijiang Shipbuilding to Buy Stake From Fairfax, Washington Family Affiliates

DJ

Lezen

10 mrt 2026, 23:35 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Edges Higher as It Faces Opposing Forces -- Market Talk

DJ

Lezen

10 mrt 2026, 23:06 UTC

Winsten

Oracle Raises 2027 Sales View as AI Demand Outpaces Supply -- Update

DJ

Lezen

10 mrt 2026, 22:51 UTC

Belangrijke Nieuwsgebeurtenissen

Deleted Tweet From Energy Secretary Sends Oil Markets on Another Wild Ride -- Updated

DJ

Lezen

10 mrt 2026, 21:39 UTC

Acquisities, Fusies, Overnames

Bill Ackman Has a Stroke of Genius. Buy His New Fund and Get Shares of His Pershing Square IPO. -- Barrons.com

DJ

Lezen

10 mrt 2026, 21:21 UTC

Winsten

Oracle Stock Jumps on Earnings Beat. Its Cloud Business Is Taking Over. -- Barrons.com

DJ

Lezen

10 mrt 2026, 21:15 UTC

Winsten

Franco-Nevada: 2026 Total GEOs Expected to Range From 510,000 to 570,000 Ounces

DJ

Lezen

10 mrt 2026, 21:15 UTC

Acquisities, Fusies, Overnames

Paramount Skydance's Stock Fades. The Warner Bros. Merger Will Take Years to Pay Off, BofA Says. -- Barrons.com

DJ

Lezen

10 mrt 2026, 21:14 UTC

Winsten

Franco-Nevada: Methodology Replaces Previous Variable GEO Conversion Ratios Based on Prevailing Market Prices

DJ

Lezen

10 mrt 2026, 21:13 UTC

Winsten

Franco-Nevada: Beginning in 2026, Company Will Be Adopt Fixed GEO Conversion Ratios Based on the Pricing Assumptions Outlined in 2026 Guidance

DJ

Lezen

10 mrt 2026, 21:12 UTC

Winsten

Franco-Nevada 4Q Rev $597.3M >FNV

DJ

Lezen

10 mrt 2026, 21:12 UTC

Winsten

Franco-Nevada 4Q EPS $1.90

DJ

Lezen

10 mrt 2026, 20:57 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

DJ

Lezen

10 mrt 2026, 20:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

10 mrt 2026, 20:44 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

DJ

Lezen

10 mrt 2026, 20:34 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

DJ

Lezen

10 mrt 2026, 20:34 UTC

Marktinformatie
Winsten

Oracle Building More Software for Less Money After Restructuring -- Market Talk

DJ

Lezen

10 mrt 2026, 20:23 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

DJ

Lezen

10 mrt 2026, 20:16 UTC

Winsten

NIO Stock Jumps After Earnings. How the EV Maker Delivered a Surprise Profit. -- Barrons.com

DJ

Lezen

10 mrt 2026, 20:14 UTC

Winsten

Oracle Has Not Yet Initiated At-The-Market Equity Portion of Financing Program >ORCL

DJ

Lezen

10 mrt 2026, 20:14 UTC

Winsten

Oracle Said In February It Intends to Raise Up to $50 B Dollars in Debt and Equity Financing >ORCL

DJ

Lezen

10 mrt 2026, 20:13 UTC

Winsten

Oracle Raised $30 B Through Combination of Investment Grade Bonds and Mandatory Convertible Preferred Stk Within Days of Feb Announcement >ORCL

DJ

Lezen

10 mrt 2026, 20:12 UTC

Winsten

Oracle Stock Jumps on Earnings Beat -- Barrons.com

DJ

Lezen

Peer Vergelijking

Prijswijziging

Cellectar Biosciences Inc Prognose

Koersdoel

By TipRanks

407.25% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14 USD  407.25%

Hoogste 14 USD

Laagste 14 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cellectar Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

1

Buy

0

Hold

0

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Cellectar Biosciences Inc - Dist in de afgelopen 3 maanden.

Financieel

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,000.74

↓-0.73%

JNJ

Johnson and Johnson

243.67

↑ +0.49%

ABBV

AbbVie Inc

226.66

↓-0.51%

NVS

Novartis AG

161.54

↓-0.79%

AZN

AstraZeneca PLC

195.13

↑ +0.21%
help-icon Live chat